One lot of the anti-seizure medication Gabapentin made by Aurobindo Phrama is being recalled because some of the capsules are empty.
Empty capsules could result in missed doses of Gabapentin, which cause adverse health consequences ranging from a short term reduction of efficacy, short term withdrawal effect or status epilepticus a type of long-term seizure which could be life threatening.
Gabapentin is used to treat epilepsy and is also prescribed for the management of postherpetic neuralgia, also known as pain after shingles.
The epilepsy drug recall involves lot GESB14011-A Gabapentin Capsules, USP 300 mg, in 100-count bottles, with an expiration date of 12/2015 and NDC 16714-662-01. The drug was distributed through Northstar label to retail outlets nationwide.
Consumers, distributors and retailers with affected products should stop using, distributing or dispensing them and return them to the place of purchase. Consumers with questions regarding the recall can contact Aurobindo Pharma USA Pharmacovigilance group at 732-839-9400. Patients who have experienced any problems related to drugs affected by this recall should contact their doctors.
Any side effects with this product should be reported to the Food and Drug Administration (FDA) MedWatch Adverse Event Reporting Program at www.FDA.gov/MedWatch/Report.htm.